The effect of L-DOPA treatment on brain serotonin metabolism in depressed patients.
D001921:Brain / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D010919:Placebos; D011339:Probenecid; D011422:Propionates / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism*
D010648:Phenylacetates; D010919:Placebos; D011422:Propionates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid